查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945436

2026年全球關節疼痛注射市場報告

Joint Pain Injections Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，注射關節止痛藥物的市場規模迅速擴張，預計將以12.5%的複合年成長率成長，從2025年的61.2億美元成長到2026年的68.9億美元。過去幾年的成長被認為歸因於多種因素，例如關節炎和關節疾病的盛行率不斷上升、全球人口老化、對微創疼痛治療的需求不斷成長、人們對再生醫學的認知不斷提高以及專業整形外科護理的擴展。

預計未來幾年關節疼痛注射劑市場將快速成長，到2030年市場規模將達到109.6億美元，複合年成長率（CAGR）為12.3%。預測期內的成長可歸因於生物鎮痛治療方法的日益普及、對個人化醫療的日益關注、運動損傷管理的擴展、再生醫學投資的增加以及對非鴉片類鎮痛療法的偏好日益增強。預測期內的主要趨勢包括：非手術鎮痛療法的日益普及、透明質酸和富血小板血漿（PRP）注射療法的廣泛應用、對個性化鎮痛方案需求的成長、基於再生醫學的注射療法的擴展以及對門診病人鎮痛方案的日益重視。

關節炎和肌肉骨骼疾病的日益普遍預計將推動關節疼痛注射市場的發展。肌肉骨骼疾病是全球造成殘疾的主要原因之一，其中腰痛是160個國家最常見的殘疾原因。患者越來越依賴注射療法來控制疼痛和治療發炎性疾病。例如，美國獨立醫學研究機構—健康指標與評估研究所（IHME）於2023年8月發布報告稱，預計到2050年，全球將有約10億人患有骨關節炎。因此，關節炎和肌肉骨骼疾病負擔的加重正在推動關節疼痛注射市場的需求。

關節疼痛注射劑市場的主要企業正致力於創新研發，例如優先考慮患者便利性的單次注射製劑。單次注射製劑是一種藥物傳遞系統，只需一次注射即可輸送特定的活性成分，無需多次給藥即可在較長時間內提供持續的治療效果。例如，2024年7月，韓國化學公司LG化學在中國推出了用於治療膝關節骨性關節炎的新型藥物Synovian。該產品採用便利的單次注射製劑，是中國首款此類產品。該產品旨在佔據一個預計價值約2,000億韓元（約1.5億美元）的龐大市場。該產品採用專有技術開發，專注於以最小的給藥負擔提供有效的緩解，展現了滿足患者需求的創新理念。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球關節疼痛注射劑市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 永續性、氣候技術和循環經濟
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 非手術疼痛管理療法的採用率不斷提高
    • 玻尿酸和富血小板血漿注射的使用增加
    • 對個人化疼痛治療方法的需求日益成長
    • 基於再生醫學的注射療法的拓展
    • 人們越來越關注門診病人疼痛緩解方案

第5章 終端用戶產業市場分析

  • 醫院
  • 整形外科診所
  • 疼痛管理中心
  • 運動醫學診所
  • 門診治療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球關節疼痛注射劑市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球關節疼痛注射市場規模、對比及成長率分析
  • 全球關節疼痛注射市場表現：規模與成長，2020-2025年
  • 全球關節疼痛注射市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 注射型
  • 類固醇關節注射，玻尿酸注射
  • 按關節類型
  • 髖關節、膝關節和踝關節、肩關節和肘關節、脊椎椎間關節以及其他類型的關節
  • 透過分銷管道
  • 醫院藥房、零售藥房
  • 按類型細分：類固醇關節注射
  • 皮質類固醇注射，合併類固醇注射
  • 按類型細分：透明質酸注射劑
  • 單次注射玻尿酸，多劑量注射玻尿酸

第10章 區域與國家分析

  • 全球關節疼痛注射市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球關節疼痛注射市場：按國家、績效和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 關節疼痛注射市場：競爭格局及市場佔有率（2024年）
  • 關節疼痛注射市場：公司估值矩陣
  • 關節疼痛注射市場：公司概況
    • Seikagaku Corporation
    • Anika Therapeutics Inc.
    • Bioventus Inc.
    • Flexion Therapeutics Inc.
    • Ferring Pharmaceuticals Inc.

第37章：其他領先和創新企業

  • Sanofi SA, AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan NV, Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年關節疼痛注射市場：提供新機會的國家
  • 2030年關節疼痛注射市場：充滿新機會的市場區隔
  • 2030年關節疼痛注射市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MJPIA01_G26Q1

Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs are influencing the joint pain injections market by increasing costs of imported biologics, syringes, processing equipment, and cold-chain packaging materials. Orthopedic clinics and hospitals in North America and Europe are most affected due to reliance on imported injectable formulations, while Asia-Pacific faces cost pressure on biologic production inputs. These tariffs are increasing treatment costs and limiting accessibility for some patients. However, they are also encouraging local biologics manufacturing, regional formulation development, and innovation in cost-efficient injectable therapies.

The joint pain injections market research report is one of a series of new reports from The Business Research Company that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown rapidly in recent years. It will grow from $6.12 billion in 2025 to $6.89 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing prevalence of arthritis and joint disorders, aging global population, rising demand for minimally invasive pain treatments, growing awareness of regenerative therapies, expansion of orthopedic specialty care.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $10.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing adoption of biologic pain therapies, rising focus on personalized medicine, expansion of sports injury management, growing investments in regenerative medicine, increasing preference for non-opioid pain management. Major trends in the forecast period include increasing adoption of non-surgical pain management therapies, rising use of hyaluronic acid and prp injections, growing demand for personalized pain treatment approaches, expansion of regenerative medicine-based injections, enhanced focus on outpatient pain relief solutions.

The increasing prevalence of arthritis and musculoskeletal disorders is expected to drive growth of the joint pain injections market. Musculoskeletal disorders represent the leading cause of disability globally, with low back pain being the most common cause of impairment across 160 countries. Patients increasingly rely on injections for pain management and treatment of inflammatory conditions. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a U.S.-based independent health research organization, reported that nearly one billion people are projected to be living with osteoarthritis by 2050. Therefore, the growing burden of arthritis and musculoskeletal disorders is fueling demand in the joint pain injections market.

Leading companies in the joint pain injections market are concentrating on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is a type of drug delivery system designed to deliver a specific dose of medication in a single injection, offering sustained therapeutic effects over an extended period without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, introduced Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. The product aims to capture a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it demonstrates innovation in meeting patient needs, focusing on providing effective relief with minimal administration effort.

In July 2025, Johnson & Johnson MedTech, a U.S.-based provider of medical devices and healthcare solutions, partnered with Pacira BioSciences to expand early-intervention options for knee osteoarthritis. Through this collaboration, both companies aim to increase market adoption of ZILRETTA(TM), a triamcinolone acetonide extended-release injectable, improve product accessibility, and strengthen presence in the knee osteoarthritis segment. Pacira BioSciences is a U.S.-based specialty pharmaceutical company that develops and commercializes non-opioid pain management and local analgesic products, including intra-articular injections for joint pain.

Major companies operating in the joint pain injections market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus Inc., Flexion Therapeutics Inc., Ferring Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited, AstraZeneca plc

North America was the largest region in the joint pain injections market in 2025. The regions covered in the joint pain injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Joint Pain Injections Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for joint pain injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The joint pain injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections
  • 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types
  • 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies
  • Subsegments:
  • 1) By Steroid Joint Injection: Corticosteroid Injections; Combination Steroid Injections
  • 2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections; Multi-Dose Hyaluronic Acid Injections
  • Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus Inc.; Flexion Therapeutics Inc.; Ferring Pharmaceuticals Inc.; Sanofi S.A.; AbbVie Inc.; Pfizer Inc.; Teva Pharmaceutical Industries Limited; Merck & Co. Inc.; Johnson & Johnson; Sun Pharmaceutical Industries Ltd.; Zydus Lifesciences Limited; Wockhardt Ltd.; Mallinckrodt Pharmaceuticals Ltd.; Mylan N.V.; Bayer AG; Eli Lilly and Company; Ipsen SA; Takeda Pharmaceutical Company Limited; AstraZeneca plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Joint Pain Injections Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Joint Pain Injections Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Joint Pain Injections Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Joint Pain Injections Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Sustainability, Climate Tech & Circular Economy
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Non-Surgical Pain Management Therapies
    • 4.2.2 Rising Use Of Hyaluronic Acid And Prp Injections
    • 4.2.3 Growing Demand For Personalized Pain Treatment Approaches
    • 4.2.4 Expansion Of Regenerative Medicine-Based Injections
    • 4.2.5 Enhanced Focus On Outpatient Pain Relief Solutions

5. Joint Pain Injections Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Orthopedic Clinics
  • 5.3 Pain Management Centers
  • 5.4 Sports Medicine Clinics
  • 5.5 Ambulatory Care Centers

6. Joint Pain Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Joint Pain Injections Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Joint Pain Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Joint Pain Injections Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Joint Pain Injections Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Joint Pain Injections Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Joint Pain Injections Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Joint Pain Injections Market Segmentation

  • 9.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Steroid Joint Injection, Hyaluronic Acid Injections
  • 9.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
  • 9.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies
  • 9.4. Global Joint Pain Injections Market, Sub-Segmentation Of Steroid Joint Injection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Corticosteroid Injections, Combination Steroid Injections
  • 9.5. Global Joint Pain Injections Market, Sub-Segmentation Of Hyaluronic Acid Injections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections

10. Joint Pain Injections Market Regional And Country Analysis

  • 10.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Joint Pain Injections Market

  • 11.1. Asia-Pacific Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Joint Pain Injections Market

  • 12.1. China Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Joint Pain Injections Market

  • 13.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Joint Pain Injections Market

  • 14.1. Japan Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Joint Pain Injections Market

  • 15.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Joint Pain Injections Market

  • 16.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Joint Pain Injections Market

  • 17.1. South Korea Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Joint Pain Injections Market

  • 18.1. Taiwan Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Joint Pain Injections Market

  • 19.1. South East Asia Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Joint Pain Injections Market

  • 20.1. Western Europe Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Joint Pain Injections Market

  • 21.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Joint Pain Injections Market

  • 22.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Joint Pain Injections Market

  • 23.1. France Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Joint Pain Injections Market

  • 24.1. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Joint Pain Injections Market

  • 25.1. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Joint Pain Injections Market

  • 26.1. Eastern Europe Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Joint Pain Injections Market

  • 27.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Joint Pain Injections Market

  • 28.1. North America Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Joint Pain Injections Market

  • 29.1. USA Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Joint Pain Injections Market

  • 30.1. Canada Joint Pain Injections Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Joint Pain Injections Market

  • 31.1. South America Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Joint Pain Injections Market

  • 32.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Joint Pain Injections Market

  • 33.1. Middle East Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Joint Pain Injections Market

  • 34.1. Africa Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Segmentation By Joint Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Joint Pain Injections Market Regulatory and Investment Landscape

36. Joint Pain Injections Market Competitive Landscape And Company Profiles

  • 36.1. Joint Pain Injections Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Joint Pain Injections Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Joint Pain Injections Market Company Profiles
    • 36.3.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Bioventus Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Ferring Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Joint Pain Injections Market Other Major And Innovative Companies

  • Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited

38. Global Joint Pain Injections Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Joint Pain Injections Market

40. Joint Pain Injections Market High Potential Countries, Segments and Strategies

  • 40.1 Joint Pain Injections Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Joint Pain Injections Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Joint Pain Injections Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer